Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan flag Japan · Delayed Price · Currency is JPY
896.00
-1.00 (-0.11%)
Nov 18, 2026, 10:15 AM JST

TYO:4570 Revenue

Immuno-Biological Laboratories had revenue of 277.00M JPY in the quarter ending September 30, 2026, with 1.09% growth. This brings the company's total for the last twelve months to 1.08B, up 7.13% year-over-year. In the fiscal year ending March 31, 2026, Immuno-Biological Laboratories had annual revenue of 1.00B with 3.61% growth. That makes Immuno-Biological Laboratories the 38,955th largest company in the world by revenue and 3,780th in Japan.

Revenue (ttm)
1.08B
Revenue Growth
+7.13%
P/S Ratio
7.72
Revenue / Employee
20.04M
Employees
54
Market Cap
8.34B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Antibody Related Business 1.00B 99.7%
  • Cosmetics Related 2.68M 0.3%

By Geography

Chart
  • Japan 593.22M 59.0%
  • United States 180.37M 17.9%
  • Others 139.10M 13.8%
  • China 92.30M 9.2%
Fiscal year ended Mar 31, 2026 See the full TYO:4570 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.00B35.00M3.61%
Mar 31, 2025969.00M153.00M18.75%
Mar 31, 2024816.00M22.00M2.77%
Mar 31, 2023794.00M147.00M22.72%
Mar 31, 2022647.00M45.00M7.48%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.